Comparison of approaches to the treatment of postpartum hemorrhage in women after repeat cesarean section

Authors

DOI:

https://doi.org/10.15574/PP.2025.3(103).3743

Keywords:

postpartum hemorrhage, cesarean section, prophylaxis, hemostasis, obstetric complications

Abstract

The need to reduce maternal mortality and complications associated with postpartum hemorrhage remains relevant today.

Aim - to study the effectiveness of modern methods of prevention and treatment of postpartum hemorrhage in women after repeated cesarean section, including surgical, medical, and combined approaches.

Materials and methods. The study was performed as a retrospective analysis of clinical cases of women with repeated cesarean section in 2019-2024 in specialized institutions of Ukraine. The sample included 200 patients aged 25-40 years, divided into four groups depending on the applied prophylaxis and treatment. The analysis was carried out according to medical histories, taking into account the volume of blood loss (determined by the gravimetric method). Statistical processing of the results was performed using the methods of analysis of variance.

Results. The study showed that the average blood loss was the greatest in patients treated with the combined approach (standard prophylaxis + extended prophylaxis + remodeling of the lower uterine segment + compression sutures according to Bilinch) and the lowest in patients treated with the combined approach; these patients were characterized by the shortest duration of hospitalization (5.8±1.2 days) and the lowest need for additional medications (15.0%). The obtained data confirm the effectiveness of comprehensive prophylaxis in reducing blood loss and improving postoperative recovery.

Conclusions. The effectiveness of preventing postpartum hemorrhage in women after repeated cesarean section directly depends on the tactics used. The best indicators - the least blood loss, lower need for blood transfusion, shorter postoperative period and faster recovery - were recorded in patients who used only the combined approach. The results obtained indicate that this technique is the most optimal and appropriate for preventing bleeding in women with repeated cesarean section and can serve as the basis for improving clinical protocols.

The study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the institution’s Local Ethics Committee. The informed consent was obtained from patients.

The authors declare no conflict of interest.

References

Abecassis A, Wainstock T, Sheiner E, Miodownik S, Pariente G. (2024). Risk factors for early postpartum hemorrhage: A retrospective, population‐based, cohort analysis. International Journal of Gynecology & Obstetrics. 166(2): 812-818. https://doi.org/10.1002/ijgo.15414; PMid:38321817

Ai W, Zeng Y, Zhen M, Lao L, Ma Y et al. (2023). Side-effects of intravenously versus intramuscularly oxytocin for postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. Front. Pharmacol. 14: 1273771. https://doi.org/10.3389/fphar.2023.1273771; PMid:38186656 PMCid:PMC10770861

Begley CM, Gyte GM, Devane D, McGuire W, Weeks A, Biesty LM. (2019, Feb 13). Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2(2): CD007412. https://doi.org/10.1002/14651858.CD007412.pub5; PMid:30754073 PMCid:PMC6372362

Bienstock JL, Eke AC, Hueppchen NA. (2021). Postpartum hemorrhage. N Engl J Med. 384: 1635-1645. https://doi.org/10.1056/NEJMra1513247; PMid:33913640 PMCid:PMC10181876

Cannon JW. (2018). Hemorrhagic shock. N Engl J Med. 378: 370-379. https://doi.org/10.1056/NEJMra1705649; PMid:29365303

Committee on Practice Bulletins-Obstetrics. (2017, Oct). Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 130(4): e168-e186. https://doi.org/10.1097/AOG.0000000000002351; PMid:28937571

Cunningham C, Watt P, Aflaifel N, Collins S, Lambert D, Porter J et al. (2017, Feb). PPH Butterfly: a novel device to treat postpartum haemorrhage through uterine compression. BMJ Innov. 3(1): 45-54. Epub 2017 Jan 2. https://doi.org/10.1136/bmjinnov-2016-000144; PMid:28250966 PMCid:PMC5293860

Davey MA, Flood M, Pollock W, Cullinane F, McDonald S. (2021). Risk factors for severe postpartum haemorrhage: A population-based retrospective cohort study. Obstetric Anesthesia Digest. 41(2): 86. https://doi.org/10.1097/01.aoa.0000744156.40863.7b

Escobar MF, Anwar HN, Theron G et al. (2022). FIGO recommendations on the management of postpartum hemorrhage 2022. Int J Gynecol Obstet. 157; Suppl 1: 3-50. https://doi.org/10.1002/ijgo.14116; PMid:35297039 PMCid:PMC9313855

Gillissen A, van den Akker T, Caram-Deelder C et al. (2018). Association between fluid management and dilutional coagulopathy in severe postpartum haemorrhage: nationwide retrospective cohort study. BMC Pregn Childbirth. 398(18):1-9. https://doi.org/10.1186/s12884-018-2021-9; PMid:30305108 PMCid:PMC6180574

Golianovskyi O, Dziuba D, Morozova O, Herasymova T, Voloshyn O et al. (2023). Suchasnyi pidkhid do transfuziinoi terapii masyvnykh krovotech za naiavnosti anomalno invazyvnoi platsenty. Reproduktyvne zdorovia zhinky. (5): 39-45. https://doi.org/10.30841/2708-8731.5.2023.286768

Govsieiev DO, Berestovyi VO, Vorona RM, Sokol IV, Makarenko MV. (2017). Sposib zupynky krovotechi u porodilli pislia kesarevoho roztynu. Patent Ukrainy No. 117714. URL: https://uapatents.com/ua/patent/117714.

Haslinger C, Weber K, Zimmermann R. (2021, Sep 1). Vacuum-Induced Tamponade for Treatment of Postpartum Hemorrhage. Obstet Gynecol. 138(3): 361-365. https://doi.org/10.1097/AOG.0000000000004510; PMid:34352848 PMCid:PMC8366764

Heesen M, Carvalho B, Carvalho JCA, Duvekot JJ, Dyer RA, Lucas DN et al. (2019, Oct). International consensus statement on the use of uterotonic agents during caesarean section. Anaesthesia. 74(10): 1305-1319. Epub 2019 Jul 25. https://doi.org/10.1111/anae.14757; PMid:31347151

Henriquez DDCA, Bloemenkamp KWM, Loeff RM et al. (2019). Fluid resuscitation during persistent postpartum haemorrhage and maternal outcome: a nationwide cohort study. Eur J Obstet Gynecol Reprod Biol. 235: 49-56. https://doi.org/10.1016/j.ejogrb.2019.01.027; PMid:30784827

Hofer S, Blaha J, Collins PW, Ducloy-Bouthors AS, Guasch E, Labate F et al. (2023, Jan 1). Haemostatic support in postpartum haemorrhage: A review of the literature and expert opinion. Eur J Anaesthesiol. 40(1): 29-38. Epub 2022 Sep 22. https://doi.org/10.1097/EJA.0000000000001744; PMid:36131564 PMCid:PMC9794135

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT. (2022, Mar). Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents. Am J Obstet Gynecol. 226(3): 347-365. Epub 2021 Sep 14. https://doi.org/10.1016/j.ajog.2021.08.060; PMid:34534498

Kaya B, Damarer Z, Daglar K, Unal O, Soliman A, Guralp O. (2017). Is there yet a role for internal iliac artery ligation in obstetric hemorrhage with the current gain in popularity of other uterus sparing tech- niques? J Matern Fetal Neonatal Med. 30(11): 1325-1332. https://doi.org/10.1080/14767058.2016.1212333; PMid:27405790

Kogutt BK, Vaught AJ. (2019). Postpartum hemorrhage: Blood product management and massive transfusion. Semin Perinatol. 43(1): 44-50. https://doi.org/10.1053/j.semperi.2018.11.008; PMid:30527516 PMCid:PMC8015778

Leighton E, Chandraharan E. (2021, Dec). Management of Postpartum Haemorrhage. The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology: 452-461. https://doi.org/10.1017/9781108863049.058

Linde LE, Ebbing C, Moster D, Kessler J, Baghestan E et al. (2021). Recurrence of postpartum hemorrhage in relatives: A population‐based cohort study. Acta Obstetricia Et Gynecologica Scandinavica. 100(12): 2278-2284. https://doi.org/10.1111/aogs.14262; PMid:34622946

Linde LE, Ebbing C, Moster D, Kessler J, Baghestan E et al. (2022). Recurrence of postpartum hemorrhage in relatives: A population-based cohort study. Obstetric Anesthesia Digest. 42(4): 167. https://doi.org/10.1097/01.aoa.0000891560.06312.60

Linde LE, Rasmussen S, Moster D, Kessler J, Baghestan E et al. (2022). Risk factors and recurrence of cause-specific postpartum hemorrhage: A population-based study. Plos One. 17(10): e0275879. https://doi.org/10.1371/journal.pone.0275879; PMid:36240210 PMCid:PMC9565392

Muñoz M, Stensballe J, Ducloy-Bouthors AS, Bonnet MP, De Robertis E, Fornet I et al. (2019, Mar). Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus. 17(2): 112-136. DOI: 10.2450/2019.0245-18 PMid: 30865585.

Pacheco LD, Saade GR, Costantine MM, Clark SL, Hankins GD. (2016). An update on the use of massive transfusion protocols in obstetrics. Am J Obstet Gynecol. 214(3): 340-344. https://doi.org/10.1016/j.ajog.2015.08.068; PMid:26348379

Seifert SM, Lumbreras-Marquez MI, Goobie SM et al. (2022, Jun 6). Tranexamic Аcid administered during cesarean delivery in high-risk patients: maternal pharmacokinetics, pharmacodynamics, and coagulation status. Am. J. Obstet. Gynecol. S0002-9378(22)00441-0. https://doi.org/10.1016/j.ajog.2022.06.001; PMid:35679896.

Stensæth KH, Carlsen MIS, Løvvik TS, Uleberg O, Brede JR, Søvik E. (2024, May). Resuscitative endovascular balloon occlusion of the aorta (REBOA) as adjunct treatment in life threatening postpartum hemorrhage: Fourteen years' experience from a single Norwegian center. Acta Obstet Gynecol Scand. 103(5): 965-969. Epub 2024 Jan 10. https://doi.org/10.1111/aogs.14767; PMid:38197478 PMCid:PMC11019522

Published

2025-09-28